Discover how GLP-1 receptor agonists may benefit breast cancer patients by promoting weight loss and improving long-term health outcomes.
Joanne Mortimer, MD, FACP, FASCO
Advertisement
Articles by Joanne Mortimer, MD, FACP, FASCO
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmacy Times
1
US Measles Cases Climb, Raising Questions About Preparedness and Prevention
2
FDA Awards National Priority Voucher to Teclistamab Plus Daratumumab in Relapsed/Refractory Multiple Myeloma
3
Afamitresgene autoleucel: The First T-Cell Receptor Therapy on the Market
4
The Return of Belantamab Mafodotin: Past Lessons, Present Promise, and Future Impact
5
